Acquiring Company
Azurity Pharmaceuticals
Acquired Company
Covis Pharma
Woburn
ZugManufacturingBiotechnologyHealth CareMedicalPharmaceuticalHealth CareDescription
Azurity Pharmaceuticals announces the successful completion of its acquisition of Covis Group S.à r.l., now a wholly-owned subsidiary. This strategic acquisition enhances Azurity's leadership in branded pharmaceuticals and aims to better serve overlooked patients globally. The collaboration is expected to leverage the strengths of both organizations to accelerate drug development.
Quick answer
Azurity Pharmaceuticals is acquiring Covis Pharma, announced March 14, 2025. Azurity Pharmaceuticals is based in Woburn, Massachusetts, United States.
- How much did Azurity Pharmaceuticals pay for Covis Pharma?
- The deal value was not disclosed.
- What does Azurity Pharmaceuticals do?
- Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients.
- Where are Azurity Pharmaceuticals and Covis Pharma based?
- Azurity Pharmaceuticals is based in Woburn, Massachusetts, United States. Covis Pharma is based in Zug, Zug, Switzerland.
- Who are the decision-makers at Azurity Pharmaceuticals?
- Fundz holds 1 contact at Azurity Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- AbbVie acquires Cerevel Therapeutics for $45 per share (March 31, 2025)
- Lupin acquires UK-based Renascience Pharma (April 3, 2025)
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- Hikma acquires ANDA for trametinib from Novugen (April 17, 2025)
Who to call at Azurity Pharmaceuticals, and when
When Azurity Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Azurity Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Azurity Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Azurity Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Azurity Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Covis Pharma?
Covis Pharma was acquired by Azurity Pharmaceuticals, based in Woburn. The deal was reported on March 14, 2025. Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity Pharmaceuticals is privately held and operates in Manufacturing.
When did Azurity Pharmaceuticals acquire Covis Pharma?
Azurity Pharmaceuticals's acquisition of Covis Pharma was reported on March 14, 2025. Azurity Pharmaceuticals announces the successful completion of its acquisition of Covis Group S.à r.l., now a wholly-owned subsidiary. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Covis Pharma do?
Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. It is privately held, operating in Health Care, and is based in Zug.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.